Tuesday Mar 08, 2022
EBM’s anatomy: what’s the differential diagnosis mid-pandemic?
Stacy Lauderdale, Senior Director of Drug Information, and Kyle Hoelting, Senior Manager of Drug Information at Vizient, share their insights on the history and current state of evidence-based medicine within the practitioner community. They also discuss how to reverse the trend of using anecdotal experience and swing the pendulum back to increased reliance on evidenced based medicine.
Guest speakers:
Stacy Lauderdale, PharmD, BCPS
Senior Director of Drug Information
Vizient
Kyle Hoelting, PharmD, BCPS
Senior Manager of Drug Information
Vizient
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:55-2:18] Kyle and Stacy’s backgrounds
[02:19-3:45] Evidence Based Medicine definition and history
[03:46-5:54] Current state of EBM
[05:55-10:45] Basic tools of EBM
[10:46-14:29] Difference between clinical and statistical significance
[14:30-15:56] Outcomes
[15:57-18:28] Role of FDA in promoting EBM
[18:29-20:27] How pharmacy and therapeutics committees incorporate EBM
[20:28-21:15] EBM Resources
Links | Resources:
Seigfried RJ, Corbo T, Saltzberg MT, Reitz J, Bennett DA. Deciding which drugs get onto the formulary: a value-based approach Value Health. 2013 Jul-Aug;16(5):901-6.
Riegelman RK, Nelson BA. Studying a Study & Testing a Test: Reading Evidence-Based Health Research. Philadelphia: Wolters Kluwer; 2021.
Gehlbach SH. Interpreting the Medical Literature. 5th ed. New York: McGraw Hill; 2006.
Malone PM, Malone MJ, Park SK. Drug information: a guide for pharmacists. 6th ed. New York: McGraw Hill; 2014.
Subscribe Today!